Improved Medication and Care to Achieve Lipid Targets After Carotid Surgery

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 4, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
DyslipidaemiasCarotid Artery Stenoses
Interventions
BEHAVIORAL

Prompt Medication Adjustment and Intensive Follow-up

Participants receive prompt adjustment of lipid-lowering therapy perioperatively and 6-8 weeks after carotid endarterectomy to achieve guideline-recommended LDL-C targets, combined with intensive follow-up visits and laboratory monitoring. Intensive follow-up visits and laboratory monitoring of lipid parameters are performed at 6-8 weeks and again at 12-16 weeks postoperatively to optimize lipid management.

OTHER

Standard Care

Participants receive standard postoperative care according to guidelines, including lipid management and routine follow-up without additional early intervention or intensive monitoring. Lipid parameters are assessed only once at 12-16 weeks postoperatively.

Trial Locations (1)

4020

Konventhospital Barmherzige Brüder, Linz

All Listed Sponsors
collaborator

Johannes Kepler University of Linz

OTHER

lead

Barmherzige Brüder Linz

OTHER

NCT07064135 - Improved Medication and Care to Achieve Lipid Targets After Carotid Surgery | Biotech Hunter | Biotech Hunter